IntrinsicIntrinsic
← Scroll for more →

Financial Statements — TGL

Balance Sheet

(in millions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
Cash & Equivalents1.592.915.451.250.240.280.260.070.200.311.234.594.094.722.621.85
Short-term Investments--------0.170.000.500.040.17--------------
Accounts Receivable0.250.550.781.451.590.900.260.04--0.070.190.160.040.050.150.00
Inventory0.020.020.140.020.010.010.010.020.030.050.130.400.210.200.380.22
Total Current Assets9.6617.1616.994.325.5210.672.141.210.961.212.386.035.225.724.182.27
Property, Plant & Equipment0.060.071.010.740.110.110.140.180.170.200.230.280.340.350.250.34
Goodwill0.52------------------------------
Intangible Assets5.55----3.043.0415.1514.244.233.132.421.63----------
Total Non-current Assets*9.664.437.2412.279.3519.7516.965.903.322.952.550.340.470.521.360.43
Total Assets19.3221.5924.2316.5914.8730.4219.107.114.284.164.936.375.696.245.542.70
Accounts Payable0.020.020.040.020.020.150.020.030.020.180.170.040.000.090.130.03
Short-term Debt--0.06--------------0.07--------1.421.42
Total Current Liabilities4.474.813.883.523.671.300.690.830.901.081.236.473.091.066.4518.22
Total Non-current Liabilities*1.281.172.401.100.460.000.000.000.000.010.020.030.040.050.030.08
Total Liabilities5.755.976.274.624.131.300.690.830.901.091.246.503.131.116.4818.30
Retained Earnings(72.49)(68.97)(66.65)(63.54)(61.41)(37.95)(39.21)(38.98)(38.03)(36.49)(34.77)(31.44)(28.33)(25.40)(33.58)(19.72)
Total Stockholder Equity13.5715.6217.9611.9710.7429.1118.406.283.383.073.69(0.13)2.565.13(0.94)(15.60)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
Total Revenue2.411.501.080.181.150.670.300.210.291.606.7115.2618.1520.4413.4615.85
Cost of Revenue2.411.491.080.180.370.180.080.040.201.386.3715.1518.0020.2113.3015.60
Gross Profit0.000.010.000.000.790.490.220.170.090.220.350.100.150.230.160.25
Research & Development0.760.080.020.780.130.010.030.050.110.180.140.150.110.170.080.01
Selling, General & Admin(3.24)3.813.790.841.550.520.770.791.371.110.791.631.370.861.240.93
Total Operating Expenses2.834.197.671.7421.270.530.920.981.781.591.432.773.032.292.082.52
Operating Income(2.83)(4.19)(7.67)(1.74)(20.48)(0.04)(0.69)(0.81)(1.68)(1.37)(1.09)(2.66)(2.88)(2.06)(1.92)(2.27)
Interest Expense--0.000.000.000.000.00------0.000.020.05----0.05--
Pretax Income(3.47)(2.27)(3.01)(2.13)(23.13)1.26(0.22)(0.94)(1.52)(1.71)(1.19)(3.05)(2.91)(2.00)(2.12)(2.58)
Tax Provision0.050.050.10--0.330.000.010.010.02-0.000.010.060.010.010.010.00
Net Income(3.52)(2.32)(3.11)(2.13)(23.45)1.26(0.23)(0.95)(1.54)(1.71)(1.20)(3.12)(2.93)(2.01)(2.13)(2.58)
Basic EPS--(1.39)(3.47)(0.38)(20.60)1.09(0.01)(0.35)6.98(2.32)(0.03)(0.15)(0.17)(0.12)(0.11)(5.00)
Diluted EPS--(1.39)(3.47)(0.38)(20.60)1.09(0.01)(0.35)6.98(2.32)(0.03)(0.15)(0.17)(0.12)(0.11)(5.00)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q4 2023Q3 2023Q2 2023Q1 2023
Operating Cash Flow(1.69)(0.46)(2.97)(1.76)(3.66)(4.23)(0.61)(0.98)(0.55)(1.07)(3.09)(2.53)(2.41)(2.72)(1.89)
Capital Expenditures0.010.070.330.640.010.000.00--0.000.000.010.000.010.070.01
Free Cash Flow*(1.70)(0.53)(3.30)(2.41)(3.67)(4.24)(0.61)--(0.55)(1.07)(3.10)(2.54)(2.42)(2.80)(1.90)
Investing Cash Flow(0.16)(1.88)(0.33)(0.70)(1.42)(2.15)(0.71)(1.49)(0.05)0.00(0.21)0.02(0.01)(0.07)(0.01)
Financing Cash Flow0.590.067.493.475.086.411.512.440.350.07(0.07)3.141.807.80(0.08)
← Scroll for more columns →

* Derived from reported values